Sotera Health/$SHC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sotera Health
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.
Ticker
$SHC
Sector
Primary listing
Industry
Life Sciences Tools & Services
Headquarters
Employees
3,000
ISIN
US83601L1026
Website
Sotera Health Metrics
BasicAdvanced
$3.4B
135.90
$0.09
1.89
-
Price and volume
Market cap
$3.4B
Beta
1.89
52-week high
$16.75
52-week low
$9.53
Average daily volume
1.3M
Financial strength
Current ratio
2.456
Quick ratio
2.026
Long term debt to equity
555.33
Total debt to equity
559.641
Interest coverage (TTM)
2.11%
Profitability
EBITDA (TTM)
512.124
Gross margin (TTM)
55.17%
Net profit margin (TTM)
2.24%
Operating margin (TTM)
31.22%
Effective tax rate (TTM)
71.81%
Revenue per employee (TTM)
$370,000
Management effectiveness
Return on assets (TTM)
7.01%
Return on equity (TTM)
5.88%
Valuation
Price to earnings (TTM)
135.895
Price to revenue (TTM)
3.042
Price to book
8.15
Price to tangible book (TTM)
-3.48
Price to free cash flow (TTM)
31.8
Free cash flow yield (TTM)
3.14%
Free cash flow per share (TTM)
37.39%
Growth
Revenue change (TTM)
2.78%
Earnings per share change (TTM)
-53.92%
3-year revenue growth (CAGR)
5.00%
3-year earnings per share growth (CAGR)
-43.31%
What the Analysts think about Sotera Health
Analyst ratings (Buy, Hold, Sell) for Sotera Health stock.
Bulls say / Bears say
Sotera Health's subsidiary, Nelson Labs, launched Rapid Sterility Testing services, reducing product sterility test results time from 14 days to as little as 6 days, potentially enhancing customer satisfaction and operational efficiency. (Sotera Health News)
In Q1 2025, Sotera Health reported a 2.6% increase in net revenues to $255 million compared to Q1 2024, indicating positive revenue growth. (Sotera Health News)
The company projects net revenue growth of 4.0% to 6.0% and adjusted EBITDA growth of 4.5% to 6.5% for 2025, suggesting a positive financial outlook. (Sotera Health News)
Sotera Health's Q1 2025 net loss was $13 million, compared to a net income of $6 million in Q1 2024, indicating a decline in profitability. (Sotera Health News)
The company has a high debt-to-equity ratio of 559.64%, which may pose financial risks. (CNBC)
Sotera Health's stock price has declined by 55% since its IPO, underperforming the S&P 500. (The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 11 Jul 2025.
Sotera Health Financial Performance
Revenues and expenses
Sotera Health Earnings Performance
Company profitability
Sotera Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sotera Health stock?
Sotera Health (SHC) has a market cap of $3.4B as of July 11, 2025.
What is the P/E ratio for Sotera Health stock?
The price to earnings (P/E) ratio for Sotera Health (SHC) stock is 135.9 as of July 11, 2025.
Does Sotera Health stock pay dividends?
No, Sotera Health (SHC) stock does not pay dividends to its shareholders as of July 11, 2025.
When is the next Sotera Health dividend payment date?
Sotera Health (SHC) stock does not pay dividends to its shareholders.
What is the beta indicator for Sotera Health?
Sotera Health (SHC) has a beta rating of 1.89. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.